This is a small study but alarming. It indicates herd immunity may not be possible. These data “might support the prolongation of public health interventions, including social distancing, hygiene, isolation of high-risk groups and widespread testing.” http
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
RT @yaletung: Asymptomatic patients shed the virus longer (19d) and had a weaker immune response to SARS-CoV-2. Still much to be learned ab…
Unschön. Vgl. https://t.co/0hqgZvpmaG #coronavirus https://t.co/9lMjpXwSYU
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
RT @j_sato: 中国PCR検査で検出された無症状感染者37人の調査。40%が抗体検査では陰性。驚くことにウィルス排出期間が有症状感染者より長い! https://t.co/EFBedmeHXU ステイホームが効かないのは多分無症状感染者が遥かに多く、そこから感染続くか…
RT @carpe_diem0820: 中国で無症候性の37人の抗体反応と症候性の37人の抗体反応を比較 無症候性感染者は症候性感染者よりも抗体反応が低く、8週間以内に抗体が陰性化する割合は40%(vs 12.9%)と高かった Clinical and immunologic…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
RT @mab_sp125: Sobre o estudo da Nature, um fio bastante resumido de ontem mostrando a impossibilidade desse tipo de conclusão. Incrível…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
RT @mab_sp125: Sobre o estudo da Nature, um fio bastante resumido de ontem mostrando a impossibilidade desse tipo de conclusão. Incrível…
RT @SEIMC_: Las personas infectadas x #SARS_CoV_2 q son asintomáticas desarrollan una respuesta inmune más débil y más corta que las person…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
RT @mab_sp125: Sobre o estudo da Nature, um fio bastante resumido de ontem mostrando a impossibilidade desse tipo de conclusão. Incrível…
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
@AlastairHaimes Thank you! This is (in some extent) coherent with this other study from the University Hospital Zurich: https://t.co/lbMfAC1RK9
RT @j_sato: 中国PCR検査で検出された無症状感染者37人の調査。40%が抗体検査では陰性。驚くことにウィルス排出期間が有症状感染者より長い! https://t.co/EFBedmeHXU ステイホームが効かないのは多分無症状感染者が遥かに多く、そこから感染続くか…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
RT @SEIMC_: Las personas infectadas x #SARS_CoV_2 q son asintomáticas desarrollan una respuesta inmune más débil y más corta que las person…
中国PCR検査で検出された無症状感染者37人の調査。40%が抗体検査では陰性。驚くことにウィルス排出期間が有症状感染者より長い! https://t.co/EFBedmeHXU ステイホームが効かないのは多分無症状感染者が遥かに多く、そこから感染続くから。欧州で休校が効いたのは子供間の無症状感染を止めたからか。 https://t.co/nJfRuER01N
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
Aproximadamente 40% casos assintomáticos e 13% dos sintomáticos revertem para IgG negativo no início da convalescença. Isso não implica que eles possam ser reinfectados (ainda não existe um caso estabelecido de reinfecção até o momento), ...
RT @mab_sp125: Sobre o estudo da Nature, um fio bastante resumido de ontem mostrando a impossibilidade desse tipo de conclusão. Incrível…
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
RT @DrLejarazu: #COVID19 #SARSCoV2 Portadores Asintomáticos: 1-Más tiempo eliminando virus 🦠🦠que los enfermos. 2-Menor respuesta inmune (me…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
RT @mab_sp125: Sobre o estudo da Nature, um fio bastante resumido de ontem mostrando a impossibilidade desse tipo de conclusão. Incrível…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @mab_sp125: Sobre o estudo da Nature, um fio bastante resumido de ontem mostrando a impossibilidade desse tipo de conclusão. Incrível…
RT @mab_sp125: Sobre o estudo da Nature, um fio bastante resumido de ontem mostrando a impossibilidade desse tipo de conclusão. Incrível…
RT @SEIMC_: Las personas infectadas x #SARS_CoV_2 q son asintomáticas desarrollan una respuesta inmune más débil y más corta que las person…
RT @FaheemYounus: Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after…
Myth: Immunity after COVID lasts 2-3 months only Fact: No one really knows. 👇study showed antibody levels decline after 3-months in ASYMPTOMATIC patients Lack of antibodies does NOT mean lack of immunity. Protection should last for much longer. https:/
#AyudaBiblioteca Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections https://t.co/SqUBVBGFSJ
RT @ZapateroAntonio: Los asintomáticos de #COVID__19 tienen capacidad de infectar hasta 19 días y a los 2-3 meses empiezan a reducir su niv…
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @DNA_PAPA: 新型コロナの無症状感染者の詳細な情報の論文が出ました。59%で肺に異常。まじか。ウイルスまき散らす期間が長い。
RT @SEIMC_: Las personas infectadas x #SARS_CoV_2 q son asintomáticas desarrollan una respuesta inmune más débil y más corta que las person…
RT @mab_sp125: Sobre o estudo da Nature, um fio bastante resumido de ontem mostrando a impossibilidade desse tipo de conclusão. Incrível…
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @mab_sp125: Sobre o estudo da Nature, um fio bastante resumido de ontem mostrando a impossibilidade desse tipo de conclusão. Incrível…
RT @mab_sp125: Sobre o estudo da Nature, um fio bastante resumido de ontem mostrando a impossibilidade desse tipo de conclusão. Incrível…
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
Sobre o estudo da Nature, um fio bastante resumido de ontem mostrando a impossibilidade desse tipo de conclusão. Incrível também que só vira notícia estudos com mensagens pessimistas.
So #ODX-manufactured antigen assays may not be a big deal. Not sure where they are with virus assays but I prefer #AVCT with affimer-based virus assays and lots more.
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @RMConservative: And demonstrates that there are likely so many more people who had it than serology tests suggest. Remember, 70% of tho…
Doctores @doctormacias y @juliocastrom, ¿cuales son sus apreciaciones con respecto a este estudio? https://t.co/xpOEhMTFQm Me preocupa el hecho de que 40% (12/30) de los individuos asintomáticos, y 12.9% (4/31) de los individuos sintomáticos, se volvieron
E anche l'affidabilità dei sierologici pare che ce la siamo giocata.
RT @jenniferholton7: @dylanlscott If you're not referring to this study, sit down; I've got bad news. If you *are* referring to this stud…
RT @RMConservative: And demonstrates that there are likely so many more people who had it than serology tests suggest. Remember, 70% of tho…
RT @SEIMC_: Las personas infectadas x #SARS_CoV_2 q son asintomáticas desarrollan una respuesta inmune más débil y más corta que las person…
@Mal_A_Clypse @mapoli @MassGovernor @GovRaimondo @HawaiiSenate @massteacher Asymptomatic are suffering silent lung damage: https://t.co/s9orE8gVVF
Risks of using COVID-19 immunity passports: Within 2–3 months after infection COVID-19 patients showed decreased immunity to coronavirus (SARS-CoV-2) infection. It means, any one of us is susceptible to 5-6 cycles of coronavirus infections per year. http
This is disappointing. IgG levels declined sharply 2 months post #covid19 infection (71-76%). Symptomatic have more lasting responses. So, natural immunity through infection may not work. But this study has small sample sizes (30-37 people per group). ht
RT @SEIMC_: Las personas infectadas x #SARS_CoV_2 q son asintomáticas desarrollan una respuesta inmune más débil y más corta que las person…
RT @RMConservative: And demonstrates that there are likely so many more people who had it than serology tests suggest. Remember, 70% of tho…
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
Small new study, but disappointing observations. People who recovered from COVID-19 started to lose their immunity in only 2-3 months. Caveat: more research needed to see how much a reduction in antibody levels affects your potential immunity.
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @SEIMC_: Las personas infectadas x #SARS_CoV_2 q son asintomáticas desarrollan una respuesta inmune más débil y más corta que las person…
RT @jenniferholton7: @dylanlscott If you're not referring to this study, sit down; I've got bad news. If you *are* referring to this stud…
RT @ZapateroAntonio: Los asintomáticos de #COVID__19 tienen capacidad de infectar hasta 19 días y a los 2-3 meses empiezan a reducir su niv…
👀👀👀👀
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
And demonstrates that there are likely so many more people who had it than serology tests suggest. Remember, 70% of those under 60 get it asymptomatically.
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @LucyWalkerlab: People infected with #SARSCoV2 without noticeable symptoms (“asymptomatic”) can exhibit lung abnormalities upon chest CT…
@juliocastrom Doctor, ¿cual es su apreciación con respecto a este estudio? https://t.co/HwKNtm8UJc Me preocupa el hecho de que 40.0% (12/30) de los individuos asintomáticos, y 12.9% (4/31) de los individuos sintomáticos, se volvieron seronegativos para Ig
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
RT @AdultSpotDiffer: 無症候性感染の患者37例の検討。 CTでGGOは(11/37, 29.7%)、その他(10/37, 27.0%)、所見なし(16/37, 43.2%)。 無症候性感染者と軽症者のウイルス脱落期間の中央値は19日対14日。IgGレベルは軽…
RT @BallouxFrancois: ~40% asymptomatic and ~13% symptomatic cases revert to IgG negative in early convalescence. This does not imply they c…
Interesting that there is still no 'established case of re-infection' but low antibodies